End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
31.82 CNY | +1.79% | +13.12% | -2.57% |
Apr. 23 | Salubris Pharmaceuticals' Q1 Profit Falls 5% Despite 23% Rise in Operating Income | MT |
Apr. 23 | Salubris Pharmaceuticals to Raise Capital of US Unit by $35 Million | MT |
Sales 2024 * | 3.92B 543M | Sales 2025 * | 4.74B 656M | Capitalization | 34.73B 4.8B |
---|---|---|---|---|---|
Net income 2024 * | 674M 93.21M | Net income 2025 * | 826M 114M | EV / Sales 2024 * | 8.04 x |
Net cash position 2024 * | 3.2B 442M | Net cash position 2025 * | 3.18B 439M | EV / Sales 2025 * | 6.66 x |
P/E ratio 2024 * |
53.3
x | P/E ratio 2025 * |
43
x | Employees | 3,517 |
Yield 2024 * |
1.67% | Yield 2025 * |
1.37% | Free-Float | 38.31% |
1 day | +1.79% | ||
1 week | +13.12% | ||
Current month | +9.31% | ||
1 month | +10.22% | ||
3 months | +14.21% | ||
6 months | +4.33% | ||
Current year | -2.57% |
Managers | Title | Age | Since |
---|---|---|---|
Jie Yan
CEO | Chief Executive Officer | 51 | 05-12-31 |
Ai Zhen Li
CHM | Chairman | 54 | 04-02-29 |
Yun Kong
DFI | Director of Finance/CFO | 51 | 21-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Cheng Hai Ye
BRD | Director/Board Member | 80 | 98-11-02 |
Sing Ye
CHM | Chairman | 49 | 04-06-30 |
Jian Feng Yang
BRD | Director/Board Member | 48 | 05-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.63% | 2 M€ | -14.86% | - | |
0.46% | 2 M€ | -14.14% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-28 | 31.82 | +1.79% | 3 918 100 |
24-04-26 | 31.26 | +1.13% | 4,966,779 |
24-04-25 | 30.91 | +3.14% | 5,639,419 |
24-04-24 | 29.97 | -1.90% | 5,871,349 |
24-04-23 | 30.55 | +6.08% | 8,764,717 |
End-of-day quote Shenzhen S.E., April 28, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.57% | 4.71B | |
+20.81% | 43.34B | |
+20.44% | 21.96B | |
+13.30% | 14.09B | |
+12.97% | 13.64B | |
+39.74% | 11.43B | |
-8.59% | 6.86B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+8.46% | 5.22B |
- Stock Market
- Equities
- 002294 Stock